207 related articles for article (PubMed ID: 7883123)
21. Isolation and characterization of the human muscle glycogen synthase gene.
Orho M; Nikula-Ijäs P; Schalin-Jäntti C; Permutt MA; Groop LC
Diabetes; 1995 Sep; 44(9):1099-105. PubMed ID: 7657035
[TBL] [Abstract][Full Text] [Related]
22. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.
Bjørbaek C; Vik TA; Echwald SM; Yang PY; Vestergaard H; Wang JP; Webb GC; Richmond K; Hansen T; Erikson RL
Diabetes; 1995 Jan; 44(1):90-7. PubMed ID: 7813820
[TBL] [Abstract][Full Text] [Related]
23. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
Huang X; Orho M; Lehto M; Groop L
Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
[TBL] [Abstract][Full Text] [Related]
24. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
25. Insulin-receptor cDNA sequence in NIDDM patient homozygous for insulin-receptor gene RFLP.
Kusari J; Olefsky JM; Strahl C; McClain DA
Diabetes; 1991 Feb; 40(2):249-54. PubMed ID: 1671379
[TBL] [Abstract][Full Text] [Related]
26. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.
Hansen L; Hansen T; Vestergaard H; Bjørbaek C; Echwald SM; Clausen JO; Chen YH; Chen MX; Cohen PT; Pedersen O
Hum Mol Genet; 1995 Aug; 4(8):1313-20. PubMed ID: 7581368
[TBL] [Abstract][Full Text] [Related]
27. Detection of variants in the mitochondrial glycerophosphate dehydrogenase gene in Japanese NIDDM patients.
Takeuchi Y; Matsutani A; Oka Y
Diabetologia; 1997 Mar; 40(3):339-43. PubMed ID: 9084974
[TBL] [Abstract][Full Text] [Related]
28. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
[TBL] [Abstract][Full Text] [Related]
29. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
30. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM.
Bjørbaek C; Echwald SM; Hubricht P; Vestergaard H; Hansen T; Zierath J; Pedersen O
Diabetes; 1994 Aug; 43(8):976-83. PubMed ID: 8039605
[TBL] [Abstract][Full Text] [Related]
32. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.
Almind K; Bjørbaek C; Vestergaard H; Hansen T; Echwald S; Pedersen O
Lancet; 1993 Oct; 342(8875):828-32. PubMed ID: 8104271
[TBL] [Abstract][Full Text] [Related]
33. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM.
Saarinen L; Pulkkinen A; Kareinen A; Heikkinen S; Lehto S; Laakso M
Diabetes Care; 1998 May; 21(5):849-50. PubMed ID: 9589253
[TBL] [Abstract][Full Text] [Related]
34. Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM.
Urhammer SA; Rasmussen SK; Kaisaki PJ; Oda N; Yamagata K; Møller AM; Fridberg M; Hansen L; Hansen T; Bell GI; Pedersen O
Diabetologia; 1997 Apr; 40(4):473-5. PubMed ID: 9112026
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 4q locus associated with insulin resistance in Pima Indians. Studies in three European NIDDM populations.
Humphreys P; McCarthy M; Tuomilehto J; Tuomilehto-Wolf E; Stratton I; Morgan R; Rees A; Owens D; Stengård J; Nissinen A
Diabetes; 1994 Jun; 43(6):800-4. PubMed ID: 8194666
[TBL] [Abstract][Full Text] [Related]
36. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
Tanizawa Y; Riggs AC; Chiu KC; Janssen RC; Bell DS; Go RP; Roseman JM; Acton RT; Permutt MA
Diabetologia; 1994 Apr; 37(4):420-7. PubMed ID: 8063045
[TBL] [Abstract][Full Text] [Related]
37. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.
Sigal RJ; Doria A; Warram JH; Krolewski AS
J Clin Endocrinol Metab; 1996 Apr; 81(4):1657-9. PubMed ID: 8636384
[TBL] [Abstract][Full Text] [Related]
38. Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population.
O'Rahilly S; Krook A; Morgan R; Rees A; Flier JS; Moller DE
Diabetologia; 1992 May; 35(5):486-9. PubMed ID: 1521731
[TBL] [Abstract][Full Text] [Related]
39. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
[TBL] [Abstract][Full Text] [Related]
40. Glucokinase gene variants in the common form of NIDDM.
Chiu KC; Tanizawa Y; Permutt MA
Diabetes; 1993 Apr; 42(4):579-82. PubMed ID: 8454109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
